| 1 |
TNFSF12 |
Tumor necrosis factor ligand superfamily member 12 |
44.25% |
6.95 |
0.0002 |
| 2 |
RIPK2 |
Receptor-interacting serine/threonine protein kinase 2 |
45.02% |
13.36 |
0.0022 |
| 3 |
STK17A |
Serine/threonine kinase 17a |
47.46% |
7.58 |
0.0003 |
| 4 |
CARD14 |
Caspase recruitment domain family member 14 |
48.12% |
6.05 |
0.0001 |
| 5 |
PDCD2 |
Programmed cell death-2 |
48.51% |
4.56 |
< 0.0001 |
| 6 |
HDAC3 |
Histone deacetylase 3 |
48.82% |
7.15 |
0.0003 |
| 7 |
PSEN2 |
Presenilin 2 |
48.99% |
6.86 |
0.0002 |
| 8 |
PIM1 |
Serine/threonine-protein kinase Pim-1 |
51.28% |
17.36 |
0.0374 |
| 9 |
SST |
Somatostatin |
52.20% |
14.23 |
0.0047 |
| 10 |
RAD21 |
RAD21 homolog (S. pombe) |
53.45% |
11.91 |
0.0027 |
| 11 |
SPHK2 |
Sphingosine kinase 2 |
54.68% |
16.96 |
0.0107 |
| 12 |
RASA1 |
RAS P21 protein activator (GTPase activating protein) 1 |
54.71% |
1.79 |
< 0.0001 |
| 13 |
NME3 |
NME/NM23 nucleoside diphosphate kinase 3 |
54.96% |
8.82 |
0.0010 |
| 14 |
CASP3 |
Caspase 3, apoptosis-related cysteine peptidase |
55.20% |
8.89 |
0.0009 |
| 15 |
CYCS |
Cytochrome C |
55.76% |
7.28 |
0.0005 |
| 16 |
NME5 |
NME/NM23 nucleoside diphosphate kinase 5 |
56.02% |
8.31 |
0.0008 |
| 17 |
CARD11 |
Caspase recruitment domain family member 11 |
56.23% |
2.63 |
< 0.0001 |
| 18 |
STK17B |
Serine/threonine kinase 17b |
57.00% |
9.32 |
0.0014 |
| 19 |
SIVA1 |
SIVA1, Apoptosis-Inducing Factor |
57.09% |
8.50 |
0.0010 |
| 20 |
CTNNAL1 |
Catenin alpha-like protein |
57.13% |
8.03 |
0.0008 |
